Korea United Pharm Inc. engages in the manufacture and sale of pharmaceutical products in South Korea. It offers products in the areas of respiratory system, musculo-skeletal system, gastro-intestinal tract system, cardiovascular system, anti-cancer, anti-infectives, allergy, immune system, central nervous system, and other diseases, as well OTC drugs. The company also exports its products to approximately 40 countries. Korea United Pharm Inc. was founded in 1987 and is headquartered in Seoul, South Korea.
Research context
Korea United Pharm Inc appears in PyInvesting’s Korea Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- KRW
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Korea United Pharm Inc is currently in a long term uptrend where the price is trading 5.4% above its 200 day moving average.
From a valuation standpoint, the stock is 60.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.4.
Korea United Pharm Inc's total revenue rose by 0.3% to $57B since the same quarter in the previous year.
Its net income has dropped by 56.3% to $3B since the same quarter in the previous year.
Finally, its free cash flow grew by 5.5% to $13B since the same quarter in the previous year.
Based on the above factors, Korea United Pharm Inc gets an overall score of 4/5.